In luminal breast cancers, the PI3K pathway is one of the most highly altered pathways, and is associated with PIK3CA mutations, loss of PTEN, and abnormal downstream protein phosphorylation [37,38]. This evidence concerns the gene PIK3CA and breast carcinoma.